<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Open Science Publishers LLP</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">184</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"> http://dx.doi.org/10.31782/IJMPS.2021.11201</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>Herbal Anti-Tuberculosis Medicaments: Highlighting New Advances in Therapeutics&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Das</surname><given-names>Saptarshi</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>10</day><month>02</month><year>2021</year></pub-date><volume>)</volume><issue/><fpage>1</fpage><lpage>5</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>The bacterial illness tuberculosis (TB) is very hazardous. The condition is very contagious, and it is often transmitted from person to person by inhalation of bacteria-carrying air droplets. TB is a disease that mostly affects the lungs, but it may affect other organs as well. It has resulted in an increase in the number of orphans due to parental deaths, which is now estimated to be 10 million, with maternal mortality accounting for 6% -15% of the total, or 15% -34 percent if only indirect effects are included. A clinical technique is used to test for tuberculosis, which checks for present cough, sputum intake, fever, weight loss, and night sweats. A multidisciplinary approach is necessary to find new, critically needed anti-TB medications from natural sources. In such a complex condition, using allopathic pharmaceuticals leads to more significant consequences like cross-resistance, while natural treatments have been shown to be more beneficial in this case. The research of novel medicines for the successful weakening of the unstable sickness connected with tuberculosis is the most important requirement.&#13;
</p></abstract><kwd-group><kwd>Tuberculosis</kwd><kwd> Botanicals</kwd><kwd> Anti-tubercular</kwd><kwd> Natural</kwd><kwd> Phytoconstituents</kwd><kwd> Therapy</kwd></kwd-group></article-meta></front></article>
